Detalhe da pesquisa
1.
Evaluation of Bleeding Events Requiring Hospitalization in Patients With Atrial Fibrillation Receiving Dabigatran, Warfarin, or Antiplatelet Therapy.
J Pharm Pract
; 30(2): 214-218, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26951615
2.
Role of agents for reversing the effects of target-specific oral anticoagulants.
Am J Health Syst Pharm
; 74(2): 54-61, 2017 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27895055